Simple Summary Brain metastases are of increasing concern in the management of cancer
patients. New systemic treatment options like specific targeting agents or immune …

Despite complete surgical resection brain metastases are at significant risk of local
recurrence without additional radiation therapy. Traditionally, the addition of postoperative …

Background The objective was to evaluate the risk and predictors of developing
leptomeningeal disease (LMD) in patients with brain metastases treated with 5-fraction …

Abstract Purpose/Objective (s) This study examined changes in the clinical target volume
(CTV) and associated clinical implications on a magnetic resonance imaging linear …

Abstract Purpose of Review Recent randomized evidence has supported the use of
resection followed by stereotactic radiosurgery (SRS) as standard of care for patients with a …

Background There is growing evidence supporting the need for a short time delay before
starting radiotherapy (RT) treatment postsurgery for most optimal responses. The timing of …

Introduction Neoadjuvant stereotactic radiosurgery (NaSRS) of brain metastases has gained
importance, but it is not routinely performed. While awaiting the results of prospective …

Background Post-operative radiosurgery (SRS) of brain metastases patients is typically
planned on a post-recovery MRI, 2–4 weeks after resection. However, the intracranial …

After maximally safe neurosurgical resection of brain metastases, stereotactic radiosurgery
(SRS) is now recommended as an alternative to whole-brain radiation therapy (WBRT) …

Objective Surgery alone for metastatic brain tumors (METs) often results in local recurrence
due to microscopic residual tumor tissue. While stereotactic radiosurgery (SRS) is commonly …